Wednesday, July 9, 2025

New Alzheimer’s Drug Approved, Offers Hope for Millions

Reuters-Yonhap

The FDA has approved Donanemab, set to be marketed as Kisunla, for use in adults exhibiting early symptoms of Alzheimer’s.

CNBC reported that there are nearly 7 million Alzheimer’s patients in the U.S. alone.

The Alzheimer’s Association identifies Alzheimer’s disease as the fifth leading cause of death among adults over 65 in the U.S.

According to their projections, the number of individuals with Alzheimer’s disease in the U.S. will nearly double to 13 million.

Donanemab faced a challenging journey to approval.

Last year, the FDA rejected it due to insufficient clinical trial data. Its approval was further delayed unexpectedly in March.

Earlier this month, the FDA’s external advisory committee recommended full approval for Donanemab, foreshadowing FDA approval. The committee concluded that the benefits outweigh the risks.

Donanemab is poised to rival Leqembi, which is produced by Biogen in collaboration with its Japanese partner Eisai.

Leqembi has already begun distribution following FDA approval last summer.

Biogen and Eisai previously marketed a dementia drug called Aduhelm but halted sales recently.

Aduhelm was the first drug aimed to reduce amyloid plaques in the brains of Alzheimer’s patients.

Despite facing backlash after the advisory committee recommended against approval in 2021, the FDA ultimately approved it.

Donanemab and Leqembi represent the culmination of 30 years of development in Alzheimer’s treatment.

Both drugs are monoclonal antibodies designed to remove toxic amyloid plaques found in the patient’s brain. While they do not cure Alzheimer’s, they play a role in slowing its progression at an early stage.

However, both Donanemab and Leqembi also pose risks of severe side effects. These include brain swelling, known as brain edema, and bleeding in the brain, known as cerebral hemorrhage.

Side effects can be severe, potentially resulting in death.

During phase 3 clinical trials of Eli Lilly’s Donanemab, three patients died from these serious side effects.

Eli Lilly has added an Alzheimer’s drug to its arsenal. The company has produced GLP-1 diabetes treatment, Mounjaro, and obesity treatment, Zepbound, both based on the same active ingredient.

Eli Lilly ranks tenth globally with a market capitalization of $815.7 billion, making it the largest pharmaceutical company in the world by market cap.

Hot this week

Tesla Tanks $68B as Musk Unveils New Political Party

The New York stock market declines after Trump imposes tariffs on South Korea and Japan, with Tesla losing $68 billion in value.

Oil Prices Climb After Saudi Arabia Hikes Export Rates

Saudi Arabia's surprise oil price hike boosts international oil prices, impacting markets and South Korea's oil imports significantly.

Apple’s FaceTime May Now Pause Your Call If Nudity Is Detected

Apple introduces nudity detection in FaceTime, pausing calls when nudity is detected, raising privacy concerns among users.

Nippon Steel Eyes Comeback as World’s No.1 with Massive U.S. Push

Nippon Steel aims to boost crude steel production by 60% through U.S. Steel acquisition and significant investments in technology.

Leaked Pics Show Samsung’s Galaxy Z Fold 7 — Thinner, Lighter, and Sleek

Leaked images reveal Samsung's Galaxy Z Fold 7, featuring a thinner design, advanced specs, and set for unveiling on July 9.

Topics

Tesla Tanks $68B as Musk Unveils New Political Party

The New York stock market declines after Trump imposes tariffs on South Korea and Japan, with Tesla losing $68 billion in value.

Oil Prices Climb After Saudi Arabia Hikes Export Rates

Saudi Arabia's surprise oil price hike boosts international oil prices, impacting markets and South Korea's oil imports significantly.

Apple’s FaceTime May Now Pause Your Call If Nudity Is Detected

Apple introduces nudity detection in FaceTime, pausing calls when nudity is detected, raising privacy concerns among users.

Nippon Steel Eyes Comeback as World’s No.1 with Massive U.S. Push

Nippon Steel aims to boost crude steel production by 60% through U.S. Steel acquisition and significant investments in technology.

Leaked Pics Show Samsung’s Galaxy Z Fold 7 — Thinner, Lighter, and Sleek

Leaked images reveal Samsung's Galaxy Z Fold 7, featuring a thinner design, advanced specs, and set for unveiling on July 9.

U.S. to Hit 90 Countries With Tariffs—Unless They Make a Deal Fast

The U.S. plans to notify trading partners of tariff rates as Trump favors simpler deals over complex negotiations.

Tesla Sales Keep Slipping, But Stock Still Jumps Nearly 5%

Tesla's vehicle sales fell 13.5% year-on-year in Q2, with deliveries below market expectations, but stock surged nearly 5%.

S&P and Nasdaq Hit New Highs Ahead of July 4th Holiday

The New York stock market showed mixed results as the Dow dipped while the S&P 500 and Nasdaq hit record highs ahead of Independence Day.

Related Articles